Anne-marie Law - Net Worth and Insider Trading
Anne-marie Law Net Worth
The estimated net worth of Anne-marie Law is at least $5 Million dollars as of 2023-10-04. Anne-marie Law is the EVP and CHRO of Alexion Pharmaceuticals Inc and owns about 29,450 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $5 Million. Details can be seen in Anne-marie Law's Latest Holdings Summary section.
Transaction Summary of Anne-marie Law
Anne-marie Law Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anne-marie Law owns 4 companies in total, including Alexion Pharmaceuticals Inc (ALXN) , Hyatt Hotels Corp (H) , and Baxalta Inc (BXLT) among others .
Insider Ownership Summary of Anne-marie Law
Anne-marie Law Latest Holdings Summary
Anne-marie Law currently owns a total of 1 stock. Anne-marie Law owns 29,450 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 8, 2018, with a value of $5 Million.
Anne-marie Law Form 4 Trading Tracker
According to the SEC Form 4 filings, Anne-marie Law has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 1,862 shares on June 8, 2018, which brought Anne-marie Law around $220,703.
Insider Trading History of Anne-marie Law
Anne-marie Law Trading Performance
Anne-marie Law Ownership Network
Ownership Network List of Anne-marie Law
Ownership Network Relation of Anne-marie Law
Anne-marie Law Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Next-generation Ultomiris is approved in PNH and aHUS. Strensiq and Kanuma target ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need in hematology, nephrology, metabolic diseases, neurology, cardiology, and other areas.
Who are the key executives at Alexion Pharmaceuticals Inc?
Anne-marie Law is the EVP & Chief Experience Officer of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include EVP & Research & Development John J Orloff , EVP & Chief Compliance Officer Indrani Lall Franchini , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
Anne-marie Law Mailing Address
Above is the net worth, insider trading, and ownership report for Anne-marie Law. You might contact Anne-marie Law via mailing address: C/o Baxalta Incorporated, 1200 Lakeside Drive, Bannockburn Il 60015.